Jump Trading’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,166
Closed -$214K 294
2019
Q2
$214K Sell
3,166
-10,699
-77% -$704K 0.01% 287
2019
Q1
$901K Buy
+13,865
New +$922K 0.29% 58
2018
Q1
Sell
-8,117
Closed -$645K 387
2017
Q4
$582K Buy
+8,117
New +$616K 0.08% 182
2017
Q3
Sell
-282
Closed -$21.6K 293
2017
Q2
$20K Sell
282
-1,325
-82% -$88.2K ﹤0.01% 251
2017
Q1
$109K Buy
+1,607
New +$113K 0.04% 168
2016
Q4
Sell
-18,726
Closed -$1.39M 179
2016
Q3
$1.48M Sell
18,726
-25,644
-58% -$2.08M 0.17% 59
2016
Q2
$3.7M Buy
44,370
+39,991
+913% +$3.55M 0.16% 68
2016
Q1
$402K Sell
4,379
-8,617
-66% -$777K 0.02% 388
2015
Q4
$1.31M Buy
+12,996
New +$1.35M 0.04% 208
2015
Q3
Sell
-36,766
Closed -$4.08M 617
2015
Q2
$4.3M Buy
36,766
+20,010
+119% +$2.19M 0.08% 78
2015
Q1
$1.64M Sell
16,756
-10,150
-38% -$1.03M 0.05% 162
2014
Q4
$2.54M Buy
26,906
+4,487
+20% +$464K 0.06% 151
2014
Q3
$2.39M Buy
+22,419
New +$2.2M 0.08% 125
2014
Q2
Sell
-742
Closed -$57.8K 835
2014
Q1
$53K Sell
742
-13,314
-95% -$1.04M ﹤0.01% 627
2013
Q4
$1.06M Buy
+14,056
New +$979K 0.1% 235
2013
Q3
Sell
-404
Closed -$24.1K 552
2013
Q2
$21K Buy
+404
New +$21.1K 0.01% 285

Other funds holding GILD

Jump Trading's GILD Position: Q3 2019 in Review

Jump Trading sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 3,166 shares — an estimated $214K sold.

Jump Trading first reported a position in GILD in Q2 2013 and held it in 16 quarters. The position peaked at $4.3M in Q2 2015. 1,464 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Jump Trading reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Jump Trading sold 3,166 Gilead Sciences shares in Q3 2019, an estimated $214K.
  • Jump Trading first reported a position in Gilead Sciences in Q2 2013 and held it in 16 quarters.
  • Jump Trading's Gilead Sciences position peaked at $4.3M in Q2 2015.
  • 1,464 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Jump Trading's 13F filing for Q3 2019, filed 12 Nov 2019.